Acuitas Therapeutics Video Update￼
Acuitas Therapeutics is a global leader in the field of lipid nanotechnology. The team, led by President & CEO, Dr. Thomas Madden, is made up of a diverse group of highly experienced scientists and technical and administrative professionals – all of whom are committed to excellence in their respective roles in the organization.
The Acuitas lipid nanoparticle (LNP) delivery system is a key component of the Pfizer-BioNTech vaccine COMIRNATY®. In our latest video, Dr. Madden talks about the team’s continued commitment to innovation and our ongoing efforts to broaden the clinical applications for LNP technology. This includes working with international partners on a range of vaccines and therapeutics.
The success of our LNP technology with the COMIRNATY® vaccine has established our global reputation and has opened many doors to partner with additional internationally recognized organizations. It’s an exciting time at Acuitas as we continue with our commitment to improving human health.
You can view the video below.